1. Earnings season - Biogen, Novartis, and looking ahead to Merck — Biogen halts plans to test aducanumab — Boston Scientific ends TAVR “duopoly” -- See more on our front page news
    Plus NEW Board just launched:
    Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

The Importance of a Long Range Investment Perspective

Discussion in 'Acorda Therapeutics' started by anonymous, Apr 13, 2019 at 2:26 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    A wise investor thinks Long Term! Day to day variance in share price is just noise. We can be easily deceived by current low valuations in some companies. Again think Long Term.
     
  2. anonymous

    anonymous Guest

    A wise investor doesn’t listen to PR shill posting non stop BS on CP.

    A wise investor looks for a competent management team, robust pipeline and a demonstrated ability to execute.

    A wise investor looks at a company in the middle of a launch with the stock dropping and says No Thanks.

    A wise investor looks at ACOR and sees a negative five year trend, a non innovative, unnecessary product being launched to save the ego of L Ron.

    Good thing it’s the weekend Habib or you might be at 11 already.
     
  3. anonymous

    anonymous Guest

    There are no PR shills here...only unbiased, thoughtful and objective posts on the state of a grate company with superior Leadership, a monumental pipeline, and ENORMOUS worldwide market for a inhaled LD for PD !!!!!

    So wise investors are immune to the short term perturbations in share price. Agree ACOR has a remote probability to drop slightly more, but a stiff upside is coming as our sales take off !!!

    Lets all give praise to our Leadership !!!
     
  4. anonymous

    anonymous Guest

    ...a wise investor also blocks out those whose advice is clouded by evil motives.

    You have been posting anti-ACOR postings at CP since the day you were fired for misappropriation of funds and filing false expense reports.

    Move on. Acorda does not care about you anymore. You betrayed your family, friends and colleagues,
     
  5. anonymous

    anonymous Guest

    Habib, don’t let L Ron diminish your work over there in Mumbai. You certainly give him enough praise for everyone (especially when you respond to yourself).

    Five years of declines does not constitute short term fluctuations. It’s a trend and a fact (you know those details you have trouble dealing with).

    As for someone fudging expenses, keep guessing little buddy. I suggest L Ron give you another list of possible subversives. You’ve blamed competitors, the expense guy, some activist investor and you aren’t even in the ballpark.

    As you’ve been told, anyone can look at this fiasco and see it for what it is.
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    Please stop with the worldwide market potential, you barely have an effective infrastructure to launch in the US..... and API shortage??
     
  8. anonymous

    anonymous Guest

    YES WE HAVE A GREAT LEADERSHIP TEAM AND NOBEL-WORTHY CEO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
     
  9. anonymous

    anonymous Guest

    Caps don’t make it factual Habib. $12 a share does however blow a pretty big hole in your land of make believe.

    Keep pimpin little buddy!
     
  10. anonymous

    anonymous Guest

    finished in the $11 range today Habib.

    Looks like your Wall Street pros still aren’t buying it.

    Congrats on the new low!
     
  11. anonymous

    anonymous Guest

    A wise investor knows a bargain. ACOR is a VERY ATTRACTIVE buy at this moment. The stars have aligned and we will see a healthy uptick coming very soon !!
     
  12. anonymous

    anonymous Guest

    We will also see my meth head mother coming after gets a train pulled on her fat ass
    I’ll be letting them do man an man on ME!
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    $1.98 from your $10 target. Sit tight to buy position of this very attractive stock.... wait till it’s a penny stock... then Habib can scream of 20% move in one day
     
  15. anonymous

    anonymous Guest

    Expect a good day for ACOR!!! Very strong in the pre market this morning. !!!!!


    LEADERSHIP. Will Deliver !!!!!!
     
  16. anonymous

    anonymous Guest

     
  17. anonymous

    anonymous Guest

    Premarket doesn’t mean $&!... here’s an article on reality, which reinforces your vapid posts to rally excitement
    :
    Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. To wit, the Acorda Therapeutics, Inc. (NASDAQ:ACOR) share price managed to fall 66% over five long years. That's an unpleasant experience for long term holders. And some of the more recent buyers are probably worried, too, with the stock falling 44% in the last year. The falls have accelerated recently, with the share price down 17% in the last three months.
     
  18. anonymous

    anonymous Guest

    YES YES

    !!!!!!!!!! !!!!!!!
     
  19. anonymous

    anonymous Guest

    late bounceback yesterday could signal the final bottoming out of ACOR. If thats the case may see a nice rebound starting, ......just a thought.
     
  20. anonymous

    anonymous Guest

    Sounds like you have quite the celebration planned Habib.

    Can’t wait to hear what you have planned when ACOR hits 10.